Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Feb 24, 2026
Reporting period
Not applicable
Filed with the SEC
Feb 27, 2026
DirectorIndirect holdingOther
Context
Classification
other
Code J — not an open-market trade
Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001193125-26-076999
Filed / recorded
Feb 27, 2026, 2:45 AM UTC
Added to OQRO
Oct 6, 2026, 7:14 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
CORCEPT THERAPEUTICS INC
Issuer CIK
1088856
Ticker
CORT
Reporting person
James N Wilson
Relationship
Director
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
Feb 24, 2026
Transaction code
J
Shares / units
89,364
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
1,134,532
Ownership form
Indirect — James N. Wilson and Pamela D. Wilson Trust
Amendment
No
Footnotes from the filing
Transfer of shares without consideration to the James N. Wilson and Pamela D. Wilson Trust.
Reporting Person has voting power over the shares held by the James N. Wilson and Pamela D. Wilson Trust and James and Pamela Wilson Family Partners pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein.